New FDA-Approved Lung Cancer Treatment Offers Faster, Easier Option
Johnson & Johnson has received FDA approval for a new treatment called Rybrevant Faspro. This treatment is for people with […]
Pharmaceutical News
NADMED Launches Award to Boost Health Discoveries
NADMED, a Finnish biotech company, has introduced the NADMED Award 2026 to foster new findings in the study of metabolomics.
New Hope for Bile Duct Cancer Patients: Early Trial Results Show Promise
Genfit has shared positive early results from their phase 1b clinical trial testing a new drug, GNS561, combined with a
Pharmaceutical Updates: CAR-T Therapy, Cancer Treatments, Allergies, and More
Today, we have updates from Bristol Myers Squibb, Novartis, Agios Pharmaceuticals, and news about a proposed new framework by the
China’s Growing Role in the Global Drug Development
The world of drug development is changing, and China’s booming biotechnology industry is a big part of that. Over the
Biotech Investor Files for Bankruptcy to Protect Startup Funding
A biotech investment company called Apple Tree Partners (ATP) has filed for bankruptcy to make sure its startup companies keep
Genetic Testing Companies: What You Need to Know
Even after facing financial troubles, 23andMe had a large amount of personal genetic data from millions of people when it
BeOne’s Blood Cancer Drug Brukinsa Leads the Market, with More Innovations on the Way
BeOne, a Swiss drug company that started in China as BeiGene, is making waves in the blood cancer treatment market.
Former FDA Leaders Worry About New Vaccine Rules
A group of 12 former leaders of the US Food and Drug Administration (FDA) have shared their worries about proposed
Recent setbacks in Alzheimer’s research: What they mean for the future
Recent weeks have seen significant setbacks in the development of new treatments for Alzheimer’s disease. Two promising therapies, one from